LYMPHOCYTIC LEUKEMIA
Clinical trials for LYMPHOCYTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new LYMPHOCYTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for LYMPHOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Custom-Made vaccine takes on untreated leukemia in early trial
Disease control Recruiting nowThis early-phase study tests a personalized neoantigen vaccine (NeoVax) in 15 people with untreated chronic lymphocytic leukemia (CLL) who have a specific genetic marker (IGHV unmutated). The vaccine is designed to train the immune system to attack each person's unique cancer cel…
Matched conditions: LYMPHOCYTIC LEUKEMIA
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
MRNA cancer therapy takes on blood tumors
Disease control Recruiting nowThis early-phase trial is testing an experimental mRNA-based drug that turns the body's own cells into cancer fighters. The drug targets CD19, a protein found on certain blood cancer cells. Researchers will enroll 47 adults with B-cell lymphoma or leukemia who have run out of sta…
Matched conditions: LYMPHOCYTIC LEUKEMIA
Phase: EARLY_PHASE1 • Sponsor: Xinqiao Hospital of Chongqing • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC